Drugs / Formoterol Furoate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00604500 Background | Mar → Nov 2008 | asthma, chronic obstructive pulmonary disease | Organon and Co | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Formoterol Furoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00604500 ↗ |
| Route | Inhaled | “administered as two inhalations of MF/F MDI 50/5 mcg, twice a day” NCT00604500 ↗ |